U.S. FDA flags probable cancer-causing impurity in common heartburn drugs
September 13, 2019 at 10:20 AM EDT
The U.S. Food and Drug Administration said on Friday that some medicines containing ranitidine, including Sanofi SA's Zantac, had traces of a probable cancer-causing impurity called N-nitrosodimethylamine (NDMA) at low levels.